Immunological treatments for occupational allergy

Area of Science:

• Occupational allergy and immunology

Background:

• Avoidance of occupational triggers is key for work-related allergies.
• Immunological treatments, including immunotherapy and biological agents, are emerging as therapeutic options for IgE-mediated occupational diseases.

Discussion:

• Allergen-specific immunotherapy shows promise, particularly sublingual immunotherapy for latex allergy.
• Limited evidence exists for immunotherapy in baker's asthma and laboratory animal-induced asthma.
• Omalizumab is a potential treatment for select occupational allergy cases and to mitigate venom immunotherapy side effects.

Key Insights:

• Specific immunotherapy has demonstrated favorable outcomes in latex allergy.
• Component-resolved diagnosis and recombinant allergens are poised to refine immunotherapy.
• Omalizumab offers a therapeutic avenue for specific occupational allergies and managing immunotherapy reactions.

Outlook:

• Future research should focus on expanding immunotherapy efficacy for various occupational allergens.
• Technological advancements will likely personalize and improve specific immunotherapy.
• Further studies are needed to establish omalizumab's role in occupational allergy management.